NanoViricides, Inc Market Product Pipeline Market Review 2016
Global Markets Direct's, 'NanoViricides, Inc. - Product Pipeline Review - 2016', provides an overview of the NanoViricides, Inc.'s pharmaceutical research and development focus.
Global Markets Direct's, 'NanoViricides, Inc. - Product Pipeline Review - 2016', provides an overview of the NanoViricides, Inc.'s pharmaceutical research and development focus.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>NanoViricides</strong>, <strong>Inc</strong> <strong>Market</strong> <strong>Product</strong> <strong>Pipeline</strong> <strong>Market</strong> <strong>Review</strong><br />
<strong>2016</strong> by Radiant Insights<br />
Summary<br />
Global <strong>Market</strong>s Direct's, '<strong>NanoViricides</strong>, <strong>Inc</strong>. - <strong>Product</strong> <strong>Pipeline</strong> <strong>Review</strong> - <strong>2016</strong>', provides an overview of the<br />
<strong>NanoViricides</strong>, <strong>Inc</strong>.'s pharmaceutical research and development focus.<br />
The report provides comprehensive information on the therapeutics under development by <strong>NanoViricides</strong>, <strong>Inc</strong>.,<br />
complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration<br />
(RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its<br />
complete research and development history and the dormant and discontinued projects.<br />
Global <strong>Market</strong>s Direct's report features investigational drugs from across globe covering over 20 therapy areas and<br />
nearly 3,000 indications. The report is built using data and information sourced from Global <strong>Market</strong>s Direct's<br />
proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor<br />
presentations and featured press releases from company/university sites and industry-specific third party sources.<br />
Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that<br />
all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes<br />
ensure that the most recent developments are captured on a real time basis.<br />
Read Complete Report with TOC @ http://www.radiantinsights.com/research/nanoviricides-inc-productpipeline-review-<strong>2016</strong><br />
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision<br />
making capabilities and helps to create effective counter strategies to gain competitive advantage.<br />
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.<br />
Scope<br />
- The report provides a snapshot of the pipeline therapeutic landscape of <strong>NanoViricides</strong>, <strong>Inc</strong>.<br />
- The report provides overview of <strong>NanoViricides</strong>, <strong>Inc</strong>. including its business description, key facts, and locations and<br />
subsidiaries<br />
- The report features descriptive drug profiles for the pipeline products which includes, product description,<br />
descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities<br />
- The report covers pipeline products based on various stages of development ranging from pre-registration till<br />
discovery and undisclosed stages<br />
- The report assesses <strong>NanoViricides</strong>, <strong>Inc</strong>.'s pipeline therapeutics based on drug target, mechanism of action (MoA),<br />
route of administration (RoA) and molecule type
- The report features <strong>NanoViricides</strong>, <strong>Inc</strong>.'s out-licensed and partnered product portfolio and summarizes its<br />
dormant and discontinued projects<br />
Reasons To Buy<br />
- Evaluate <strong>NanoViricides</strong>, <strong>Inc</strong>.'s strategic position with total access to detailed information on its product pipeline<br />
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies<br />
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain<br />
competitive advantage<br />
- Identify and understand important and diverse types of therapeutics under development for <strong>NanoViricides</strong>, <strong>Inc</strong>.<br />
- Identify potential new clients or partners in the target demographic<br />
- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics<br />
- Devise corrective measures for pipeline projects by understanding <strong>NanoViricides</strong>, <strong>Inc</strong>.'s pipeline depth and focus<br />
of pipeline therapeutics<br />
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most<br />
attractive projects to enhance and expand business potential and scope<br />
Buy a Sample copy of This Report @ http://www.radiantinsights.com/research/nanoviricides-inc-productpipeline-review-<strong>2016</strong>/request-sample<br />
Table of Contents<br />
Table of Contents 2<br />
List of Tables 5<br />
List of Figures 5<br />
<strong>NanoViricides</strong>, <strong>Inc</strong>. Snapshot 6<br />
<strong>NanoViricides</strong>, <strong>Inc</strong>. Overview 6<br />
Key Information 6<br />
Key Facts 6<br />
<strong>NanoViricides</strong>, <strong>Inc</strong>. - Research and Development Overview 7<br />
Key Therapeutic Areas 7<br />
<strong>NanoViricides</strong>, <strong>Inc</strong>. - <strong>Pipeline</strong> <strong>Review</strong> 10<br />
<strong>Pipeline</strong> <strong>Product</strong>s by Stage of Development 10<br />
<strong>Pipeline</strong> <strong>Product</strong>s - Monotherapy 11<br />
<strong>NanoViricides</strong>, <strong>Inc</strong>. - <strong>Pipeline</strong> <strong>Product</strong>s Glance 12<br />
<strong>NanoViricides</strong>, <strong>Inc</strong>. - Early Stage <strong>Pipeline</strong> <strong>Product</strong>s 12<br />
Preclinical <strong>Product</strong>s/Combination Treatment Modalities 12<br />
Discovery <strong>Product</strong>s/Combination Treatment Modalities 13<br />
<strong>NanoViricides</strong>, <strong>Inc</strong>. - Drug Profiles 14<br />
ADIFBase-I 14<br />
<strong>Product</strong> Description 14<br />
Mechanism of Action 14<br />
R&D Progress 14<br />
DengueCide 15<br />
<strong>Product</strong> Description 15<br />
Mechanism of Action 15<br />
R&D Progress 15<br />
EKCCide-I 16<br />
<strong>Product</strong> Description 16<br />
Mechanism of Action 16<br />
R&D Progress 16<br />
Herpecide 17<br />
<strong>Product</strong> Description 17<br />
Mechanism of Action 17<br />
R&D Progress 17
HIVCide-I 19<br />
<strong>Product</strong> Description 19<br />
Mechanism of Action 19<br />
R&D Progress 19<br />
HIVCide-II 20<br />
<strong>Product</strong> Description 20<br />
Mechanism of Action 20<br />
R&D Progress 20<br />
NVINF-1 21<br />
<strong>Product</strong> Description 21<br />
Mechanism of Action 21<br />
R&D Progress 21<br />
NVINF-2 23<br />
<strong>Product</strong> Description 23<br />
Mechanism of Action 23<br />
R&D Progress 23<br />
Read Complete Report with TOC @ http://www.radiantinsights.com/research/nanoviricides-inc-productpipeline-review-<strong>2016</strong><br />
About Us:<br />
Radiant Insights <strong>Inc</strong>. is a platform for companies looking to meet their market research and business intelligence<br />
requirements. We assist and facilitate organizations and individuals procure market research reports, helping them<br />
in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries<br />
and a host of micro markets. In addition to over extensive database of reports, our experienced research<br />
coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research<br />
solutions.<br />
Contact Details:<br />
Michelle Thoras<br />
Corporate Sales Specialist, USA<br />
Radiant Insights, <strong>Inc</strong><br />
28 2nd Street,<br />
Suite 3036 San Francisco,<br />
CA 94105 United States<br />
Phone: 1-415-349-0054<br />
Toll Free: 1-888-202-9519<br />
Website: http://www.radiantinsights.com/<br />
Email: sales@radiantinsights.com<br />
Visit our Blog: http://chemicalsandmaterialsri.blogspot.com